Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy
ctDNA assessment is a reliable tool for detecting MRD and predicting outcomes in EC patients after esophagectomy. This approach provides earlier indications of recurrence and can guide personalized postoperative management.
Authors
- Shinichiro Ikeda (ORCID: https://orcid.org/0000-0001-8318-9379)
- Masatoshi Eto
- Yasue Kimura (ORCID: https://orcid.org/0000-0002-7454-9755)
- Tomoharu Yoshizumi (ORCID: https://orcid.org/0000-0002-4497-1816)
- Qingjiang Hu (ORCID: https://orcid.org/0000-0002-8313-5861)
- Eiji Oki (ORCID: https://orcid.org/0000-0002-9763-9366)
- Mitsuhiko Ota (ORCID: https://orcid.org/0000-0002-5968-0739)
- Tomonori Nakanoko (ORCID: https://orcid.org/0000-0001-6486-9889)
- Yasushi Tanaka (ORCID: https://orcid.org/0009-0000-1895-9226)
Institutions
- Kyushu University (JP)
Publication Details
- Journal
- BJC Reports
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1038/s44276-025-00158-x
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00